Catecholamine equilibration gradients of isolated chromaffin vesicles induced by the ionophore X-537A  by Johnson, R.G. & Scarpa, A.
Volume 47. number 1 FEBS LETTERS October 1974 
CATECHOLAMINE EQUILIBRATION GRADIENTS OF ISOLATED CHROMAFFIN 
VESICLES INDUCED BY THE IONOPHORE X-537A 
R. G. JOHNSON and A. SCARPA 
Johnson Research Foundation, University of Pennsylvania, Philadelphia, Pa. 19174, USA 
Received 12 August 1974 
1. Introduction 
The ionophore X-537A, a monocarboxylic acid 
antibiotic, is able to form lipophilic complexes with 
monovalent and divalent ions [ 1,2] . A number of 
studies have reported the ability of X-537A to increase 
calcium fluxes through certain biological membranes 
such as mitochondria [3] and sarcoplasmic reticulum 
[4,51. 
More recently, X-537A has been used to investigate 
the role of Ca2 + as secretagogue of neurotransmitters 
and hormones from endogenous stores of perfused 
organs. Accumulating evidence has shown that X-537A 
prompts a release of histamine from mast cells [6,7], 
neurotransmitters from chick retina [8], vasopressin 
from neurohypophysis [ 91, norepinephrine from 
peripheral adrenergic neurones [lo] , and from endo- 
genous stores of myocardia [ 1 l] . These studies have 
interpreted the secretagogue ffect of X-537A as being 
a consequence of Ca2 + mobilization across the storage 
vesicles. However, X-537A was also shown to form 
lipophilic complexes with biological amines and to 
transport them across apolar moieties of model systems 
[ 11 ,121. Direct transport of norepinephrink from 
endogenous stores of perfused hearts has been recently 
postulated [13,14]. 
This study was undertaken to examine the effect of 
X-537A on catecholamine release from chromaffin 
vesicles isolated from beef adrenal medulla. The results 
suggest hat X-537A induces catecholamine release 
directly by facilitating norepinephrine transport across 
the lipid phase of the membrane, rather than indirectly 
by increasing the permeability of the vesicles to Ca’+. 
A preliminary report has already been published [ 151. 
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2. Materials and methods 
Bovine adrenal medulla chromaffm granules were 
isolated on a D2 0-Ficoll-Sucrose density gradient by 
the method of Trifaro and Dworkind [ 161. Although 
expensive, this procedure allows the granules to be iso- 
lated in an isotonic medium unlike previous preparatory 
procedures [ 17,181. Once isolated, the granules were 
suspended in 0.27 M sucrose- 10 mM Tris (hydroxy- 
methyl) aminomethane, pH 7.0. The granules were 
stable for several days if stored at 4°C. After addition 
of the ionophore, 1 ml samples were taken from the 
granule suspension and spun down rapidly in an 
Eppendorf Model 3200 Centrifuge. The catecholamines 
were assayed fluorimetrically in the supernatant on a 
Fluorispec Model SF-100 Fluorescence Spectrophoto- 
meter by a modified method of von Euler and Lishajko 
[ 191 with excitation at 410 nm and emission at 520 nm. 
All experiments were carried out at 4°C. Protein 
concentration was measured by the biuret method. 
Catecholamine transport across a chloroform phase 
was measured using the method of Pinkerton et al. [20] 
in a vessel modified as described previously [ 111. 
Aliquots of the buffers were withdrawn at intervals and 
counted in a Tricarb scintillation counter for both ’ 4 C 
and 3H. 
Norepinephrine HC 1 and epinephrine bitartrate 
were purchased from Sigma, St. Louis, MO. X-537A 
and its derivatives were generous gifts of Dr J. Berger 
of Hoffman-La Roche. A23 187 and monensin were 
supplied by Dr R. Hamill of Eli Lilly & Co. d,l- 
Norepinephrine-7-3H (specific activity 3.7 Ci/mM) and 
d,l-epinephrine-7-14C (specific activity 55.3 m Ci/mM) 
were purchased from New England Nuclear. 
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3. Results 
Fig. 1 illustrates the dose-dependent release of 
catecholamines from isolated chromaffin vesicles 
induced by X-537A. The addition of various concen- 
trations of X-537A to vesicles incubated at 4°C in the 
absence of added Ca” caused, after 30 min, a release 
of catecholamines comparable to that obtained after 
extensive ultrasonic disruption of the vesicles. At 
shorter times, the relase of catecholamines was 
dependent upon the concentrations of X-537A and 
was kinetically resolvable. Faster rates of release were 
observed at higher temperatures. In all the X-537A 
concentrations, a biphasic release was obtained, which 
suggested that one catecholamine may be preferentially 
transported. Bovine chromaffin granules contain 3 
times more epinephrine than norepinephrine. On the 
other hand, it has been reported that, in toluene-butanol, 
the affinity of X-537A for norepinephrine is 28 times 
greater than that for epinephrine [ 121 . Reliable 
measurements of norepinephrine and epinephrine in 
the same sample are difficult to obtain and accurate 
experiments using both radiochemical and 
fluorescence techniques are now under way to deter- 
mine whether norepinephrine is preferentially released 
during the first initial phase after addition of X-537A. 
Fig. 2 shows the results of an experiment in which 
release of endogenous catecholamines was measured 
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Fig. 1. The effect of various concentrations of X-537A on 
catecholamine release by chromaffin granules. The reaction 
mixture contained 270 mM sucrose-10 mM Tris (hydroxy- 
methyl) aminomethane, pH 7.2 and 0.55 mg chromaffin 
vesicles/ml. Vol. 10 ml. Temperature, 4°C. 
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Fig. 2. The release of catecholamines induced by ionophores 
X-537A and A23187 under the conditions shown. Experimental 
conditions as in fig. 1. Catecholamine release was measured 
25 minutes after the additions reported in the figure. 
under various conditions. After 25 minutes of incubation 
of the granules in an isotonic buffered reaction mix- 
ture, only a small fraction of the endogenous cate- 
cholamines was found in the supernatant. The amount 
released was slightly increased in the presence of Ca’ + 
or Mg’+. The presence of X-537A caused a release of 
catecholamines of about 80% of the total content of 
isolated chromaftin vesicles. The release was greater 
and faster in the presence of ethylene glycol-his@ 
aminoethyl ether)N,N’-tetracetic acid (EGTA). The 
presence of Ca2+ diminishes both the amount and rate 
of catecholamine release. The effect of X-537A was 
insensitive to ruthenium red, a compound known to 
compete with Ca* for binding sites and block Ca2+ 
transport in a variety of biological membranes [21,22] . 
A23 187, another ionophore known to equilibrate Ca2+ 
across several biological membranes more effectively 
than X-537A [23,24], produced only a small release 
of catecholamines. Even at a concentration of 80 PM 
(not shown), A23 187 was unable to produce a signifi- 
cant release of catecholamines. Contrary to X-537A, 
the effect of A23 187 was greater in the presence of 
added Ca2+. Other ionophores known through differ- 
ent mechanisms to transport monovalent cations across 
articial and biological membranes (valinomycin, mo- 
nencin, nigericin) were without effect, even at high 
concentrations (5-10 1M). These data suggest hat the 
release of catecholamines induced by X-537A may not 
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Fig. 3. X-537A-mediated transport of catecholamines across a chloroform phase as described in Materials and methods. 120 mM 
[ 3 H] norepinephrine and 120 mM [ I4 Clepinephrine plus 5 mM ascorbate and 20 mM Na morpholinopropane sulfonate (MOPS), 
pH 7.2 were placed in one aqueous phase Transport was monitored by the appearence of [ 3 H] norepinephrine and [I *Cl epinephrine 
in the opposite aqueous compartment. X-537A was added to the chloroform phase such that the final concentration was 330 MM. 
be secondary to Ca2+ mobilization induced by the iono- 
phore. 
The ability of X-537A to directly transport cate- 
cholamines across the vesicle membrane and its 
specificity toward epinephrine-norepinephrine transport 
were tested in the experiment of fig. 3. A layer of 
chloroform was used to separate two sides of a U- 
shaped chamber containing two buffered aqueous 
phases. [ 3 H] norepinephrine and [ l4 C] epinephrine 
were added to one of the aqueous phases on one side 
of the chamber, and aliquots of the other aqueous 
layer on the other side of the chamber were removed 
for counting at intervals. X-537A was added to the 
chloroform layer and the transport of catecholamines 
across the chloroform phase was measured as the 
appearance of labelled material in the order aqueous 
compartment. As shown in the figure, X-537A was 
able to transfer both epinephrine and norepinephrine 
through the organic solvent. At equimolar concentra- 
tions, the transport of norepinephrine was 3-6 times 
greater than that of epinephrine. A23 187 and other 
monovalent cation ionophores were without effect. 
These data show that X-537A is able to transport 
catecholamines across an apolar moiety and provide 
further evidence that the release of catecholamine by 
the granules may result from primary transport through 
the granules rather than equilibration of Ca2 + gradients. 
4. Diicussion 
Calcium’s role as releasing element in the adrenal 
medulla has been well documented [25] . Douglas and 
Rubin have proposed that calcium acts as such by 
serving as the stimulus-secretion coupling agent on the 
medullary chromaffin cell [26] . Release then would be 
expected by X-537A in the presence of calcium in 
light of its ability to act as a mobile carrier for calcium 
across biological membranes [3-5,121. X-537A was 
recently shown to release neurotransmitters and 
hormones from endogenous stores of various tissues 
and this effect has been attributed to the disturbance 
of Ca2+ gradients induced by the ionophore [6-lo]. 
Our results show that X-537A is able to release 
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catecholamines from chromaffin vesicles isolated from 
beef adrenal medulla. The evidence presented also 
indicates that catecholamine release from the vesicles 
results primarily from a direct transport of catechola- 
mines across the membranes via X-537A rather than 
secondarily to an increase of membrane Ca*+ 
permeability induced by the ionophore. This conclu- 
sion is based on the following evidence: 
(a) The release of catecholamines induced by X- 
537A was independent of calcium ion concentrations 
surrounding the vesicles. If there was any effect, Ca*+ 
presence decreased both extent and rate of catechola- 
mine release. This may be attributable to the formation 
of a complex between calcium and X-537A, with 
consequent decrease of the amount of ionophore 
available for the transport of catecholamines. 
(b) The effect of X-537A was specific and occurred 
in a variety of reaction mixtures of different composi- 
tion. A23 187, another ionophore which equilibrates 
Ca*+ gradients across several biological membranes 
[23,24] was ineffective in releasing catecholamines. 
Also without effect were several other ionophores 
which affect protons and monovalent cation distribu- 
tion across membranes. 
(c) X-537A (and no other ionophores) effectively 
transports both norepinephrine and epinephrine 
through apolar moieties of model systems (ref. [ 11,121 
and fig. 3). 
In view of these results and the ability of X-537A 
to form lipophilic complexes with several biological 
amines [ 121, recent studies which have shown a 
release of various transmitters induced by X-537A and 
attributed the release as being secondary to Ca’+ 
mobilization [6,7,10] may require reconsideration. In 
addition, our results offer a reasonable explanation 
for the powerful inotropic action of X-537A when 
injected in perfused heart preparations. Since the 
effect of X-537A on increasing heart work, flow rate 
and heart rate was absent in hearts from reserpinized 
animals and in the presence of/3-blocking agents, it was 
suggested that the inotropic effect of X-537A was due 
to a mobilization of norepinephrine from myocardial 
endogenous stores [ 11,13,14]. The results presented 
indicate that this mechanism is feasible and that 
disturbances of Ca*+ distribution may not be required. 
Compounds that affect specific permeabihties of 
biological membranes offer tools for perturbing cellular 
functions and provide useful methods for investigating 
120 
transport mechanisms. Along this line, X-537A offers 
a powerful tool for the study of the nature of the 
secretory processes and storage complexes in chromaffin 
granules and in other systems. 
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